Profile
Vincent W.
Coljee was the founder of Excelimmune, Inc. which was founded in 2006, where he held the title of Chief Scientific Officer from 2010 to 2013.
Currently, he holds the title of Principal at Harvard University.
In the past, he held the title of Principal at Symphogen A.
Vincent W. Coljee active positions
| Companies | Position | Start |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Vincent W. Coljee
| Companies | Position | End |
|---|---|---|
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Corporate Officer/Principal | - |
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and biotechnology services | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and biotechnology services | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
- Stock Market
- Insiders
- Vincent W. Coljee
















